AgeX Therapeutics, Inc.

AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. Our proprietary technology is based on telomerase-mediated cellular immortality and regenerative biology. Our mission is to apply our comprehensive experience in fundamental biological processes of human aging to extend the human healthspan.

Informational videos are presented for editorial and educational purposes. Information relating to the Company's operations have associated risks and uncertainties, therefore we refer our viewers to BioTime's (NYSE MKT: BTX) filings with the SEC for more detailed information about the Company.